Work

Vericiguat versus sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction in China: a cost-utility analysis

Year: 2025

Type: article

Source: Acta cardiologica. Supplementum

DOI: 10.1080/00015385.2025.2484848

Authors: Xingyuan Zhao, Nan Hu, Liying Wang, Zongling Xia

Institutions: Soochow University, Soochow University, The First People's Hospital of Changzhou

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Jiangsu Pharmaceutical Association, Changzhou Science and Technology Bureau

OpenAlex ID: W4408993259

FWCI: 1.884

Cites: 29

Cited by: 2

Related to: 10